Myomo Inc Stock Today
| MYO Stock | USD 5.13 0.04 0.79% |
Performance8 of 100
| Odds Of DistressLess than 38
|
Myomo is selling at 5.13 as of the 26th of November 2024; that is 0.79 percent increase since the beginning of the trading day. The stock's open price was 5.09. Myomo has about a 38 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Myomo Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2024 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 12th of June 2017 | Category Healthcare | Classification Health Care |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. Myomo operates under Medical Devices classification in the United States and is traded on AMEX Exchange. The company has 30.25 M outstanding shares of which 1.02 M shares are now shorted by investors with about 10.04 days to cover. More on Myomo Inc
Moving together with Myomo Stock
Moving against Myomo Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Myomo Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Paul Gudonis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | MYOB Group Ltd | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsMyomo can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Myomo's financial leverage. It provides some insight into what part of Myomo's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Myomo Inc (MYO) is traded on NYSE MKT Exchange in USA. It is located in 137 Portland Street, Boston, MA, United States, 02114 and employs 101 people. Myomo is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 153.95 M. Myomo Inc runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 30.25 M outstanding shares of which 1.02 M shares are now shorted by investors with about 10.04 days to cover.
Myomo Inc has about 5.35 M in cash with (6.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46.
Check Myomo Probability Of Bankruptcy
Ownership AllocationMyomo Inc maintains a total of 30.25 Million outstanding shares. Over half of Myomo's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Myomo Ownership Details
Myomo Historical Income Statement
Myomo Stock Against Markets
Myomo Corporate Executives
Elected by the shareholders, the Myomo's board of directors comprises two types of representatives: Myomo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Myomo. The board's role is to monitor Myomo's management team and ensure that shareholders' interests are well served. Myomo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Myomo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Henry | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share 0.835 | Quarterly Revenue Growth 0.813 | Return On Assets (0.31) | Return On Equity (0.83) |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.